Cencora, Inc. announced on December 9, 2024, the successful closing of its public offering of $1.8 billion aggregate principal amount of senior notes. This offering included $500 million of 4.625% Senior Notes due December 15, 2027, $600 million of 4.850% Senior Notes due December 15, 2029, and $700 million of 5.150% Senior Notes due February 15, 2035.
The offering was made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchange Commission. The completion of this financing provides capital for the company's strategic initiatives.
Cencora intends to use the net proceeds from this offering to finance the acquisition of the majority of Retina Consultants of America and related fees and expenses, as well as for general corporate purposes.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.